Detailed Analysis of the Scope and Claims of United States Patent 3,483,221
Introduction
United States Patent 3,483,221, titled "(isopropylamino)-2-hydroxy-3-(naphthyl)-propionitrile and related compounds," is a patent that describes a series of chemical compounds with specific pharmacological properties. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.
Patent Overview
Invention Description
The patent describes a class of chemical compounds, particularly focusing on (isopropylamino)-2-hydroxy-3-(naphthyl)-propionitrile and its derivatives. These compounds are highlighted for their valuable pharmacological properties, especially their inhibiting effect on adrenergic β-receptors[5].
Claims
The patent includes several claims that define the scope of the invention:
- Claim 1: This claim specifies the general structure of the compounds, including the (isopropylamino)-2-hydroxy-3-(naphthyl)-propionitrile core.
- Subsequent Claims: These claims detail specific variations of the compound, including different substituents and derivatives, as well as methods for their preparation and use.
Scope of the Invention
Pharmacological Properties
The compounds described in the patent are valued for their pharmacological effects, particularly their ability to inhibit adrenergic β-receptors. This makes them potentially useful in the treatment of conditions related to the cardiovascular system, such as hypertension and heart failure[5].
Synthesis and Preparation
The patent outlines methods for synthesizing these compounds, including the necessary reactants, conditions, and steps involved in their preparation. This is crucial for ensuring that the compounds can be reliably produced and used in various applications.
Patent Landscape Analysis
Competitive Landscape
To understand the broader patent landscape, it is essential to identify other patents and patent applications in the same technological area. Here are some key points:
- Related Patents: Other patents related to adrenergic β-receptor inhibitors would be relevant. These could include patents from other companies or research institutions working on similar compounds or therapeutic applications.
- Inventor and Assignee: The inventors and assignees of the patent can provide insights into the organizations actively working in this field. This could include pharmaceutical companies, research institutions, or individual inventors[3].
Geographical Distribution
The geographical distribution of patent filings can indicate where the innovation is most active. For example:
- USPTO Filings: The patent in question is filed with the USPTO, but similar patents might also be filed in other jurisdictions such as the European Patent Office (EPO), Japan Patent Office (JPO), or the World Intellectual Property Organization (WIPO)[1].
Technological Trends
Analyzing the patent landscape can reveal trends in technological development:
- Adrenergic β-Receptor Inhibitors: The focus on adrenergic β-receptor inhibitors suggests a significant interest in cardiovascular treatments. Other patents in this area might indicate advancements in this field, such as new compounds, delivery methods, or therapeutic applications[3].
Tools for Patent Landscape Analysis
To conduct a comprehensive patent landscape analysis, several tools and resources can be utilized:
- Patent Public Search: The USPTO's Patent Public Search tool can be used to find related patents and published patent applications. This tool provides enhanced access to prior art and can help in identifying similar inventions[1].
- Global Dossier: This service allows users to view the file histories of related applications from participating IP Offices, which can be useful in understanding the global context of the patent[1].
- Common Citation Document (CCD): The CCD application consolidates citation data from multiple patent offices, helping to visualize the prior art cited by different offices for the same invention[1].
Key Takeaways
- Pharmacological Significance: The patent highlights compounds with significant pharmacological properties, particularly in inhibiting adrenergic β-receptors.
- Synthesis Methods: Detailed methods for synthesizing these compounds are provided, ensuring reproducibility.
- Competitive Landscape: Understanding the competitive landscape involves identifying related patents, inventors, and geographical distribution of filings.
- Technological Trends: The patent landscape analysis reveals trends in cardiovascular treatment innovations.
FAQs
Q: What is the main pharmacological property of the compounds described in US Patent 3,483,221?
A: The compounds described in the patent are valued for their inhibiting effect on adrenergic β-receptors.
Q: How can one conduct a patent landscape analysis for this patent?
A: Use tools like the USPTO's Patent Public Search, Global Dossier, and Common Citation Document (CCD) to identify related patents, inventors, and geographical distribution of filings.
Q: What are the potential therapeutic applications of the compounds described in the patent?
A: The compounds are potentially useful in the treatment of conditions related to the cardiovascular system, such as hypertension and heart failure.
Q: Where can one find more information about similar patents filed in other jurisdictions?
A: Databases from other International Intellectual Property offices such as the EPO, JPO, and WIPO can provide information on similar patents filed globally[1].
Q: What is the significance of the synthesis methods described in the patent?
A: The synthesis methods ensure that the compounds can be reliably produced and used in various applications.
Sources
- USPTO - Search for patents. Retrieved from https://www.uspto.gov/patents/search
- Congress.gov - SE.NATE-Friday, May 31, 1974. Retrieved from https://www.congress.gov/93/crecb/1974/05/31/GPO-CRECB-1974-pt13-3.pdf
- IP Checkups - How to perform a patent landscape analysis in 5 key steps. Retrieved from https://www.ipcheckups.com/patent-landscape-analysis-how-to-5-steps/
- Google Patents - EP3483221B1 - Talc particulaire et ses utilisations. Retrieved from https://patents.google.com/patent/EP3483221B1/fr
- Google Patents - US3483221A - (isopropylamino)-2-hydroxy-3-(naphthyl)-propionitrile and related compounds. Retrieved from https://patents.google.com/patent/US3483221A/en
